Arthroscopic surgical management of shoulder secondary to shoulder injury related to vaccine administration (SIRVA): a case report

Wong, Willis; Okafor, Chinedu; Belay, Elshaday; Klifto, Christopher S.; Anakwenze, Oke

doi:10.1016/j.jse.2021.01.027

Cited by 9 publications

(13 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A case report of two military personnel treated with early corticosteroid injection after SIRVA had complete resolution of symptoms within 1 month. 11 A case report of SIRVA managed arthroscopically in a patient who had 3 months of persistent symptoms despite medical management showed similar efficacy with immediate improvement in shoulder symptoms. 11 While we did not send any tissue samples for gross or microscopic pathology analysis, surgeons considering surgical debridement for SIRVA may consider utilizing this diagnostic tool to better understand the underlying pathophysiology of this condition.…”

Section: Discussionmentioning

confidence: 92%

“…Although these rarely require operative management, there are several reports of good results after surgical intervention. 11 , 12 To date, there is very little information on the management of SIRVA after COVID-19 vaccine administration. 10 To our knowledge, this report represents the first case of COVID-19 vaccine related SIRVA that underwent acute operative management.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Arthroscopic debridement for acute hemorrhagic subacromial bursitis following COVID-19 vaccine administration: A case report

Mayer¹,

Gajewski²,

Bernthal³

et al. 2022

Shoulder & Elbow

View full text Add to dashboard Cite

The rapid rollout of vaccinations in response to the COVID-19 pandemic has led to their widespread distribution and administration throughout the world. The benefit of these vaccinations in preventing the spread of the disease and diminishing symptoms in patients who contract COVID-19 has been fervently studied and reported. While vaccinations remain an effective and generally safe method of limiting disease transmission and virus-related mortality, vaccine administration is not completely without risk. Shoulder injuries related to vaccine administration (SIRVA) have been described with previously available vaccines but have yet to be widely reported in the COVID-19 vaccination population. We present a case report of a young, high-functioning patient who presented with acute subacromial bursitis after COVID-19 vaccine administration due to improper vaccination technique. The patient was treated with arthroscopic shoulder surgery and had near immediate relief of shoulder symptoms.

show abstract

Section: Discussionmentioning

confidence: 92%

Section: Discussionmentioning

confidence: 99%

Arthroscopic debridement for acute hemorrhagic subacromial bursitis following COVID-19 vaccine administration: A case report

Mayer¹,

Gajewski²,

Bernthal³

et al. 2022

Shoulder & Elbow

View full text Add to dashboard Cite

show abstract

“…Wong et al 30 presented another case in which a patient experienced increased shoulder pain 48 hours after receiving the influenza vaccination. The patient was diagnosed via MRI with rotator cuff bursitis and bursal foreign body reaction.…”

Section: Discussionmentioning

confidence: 99%

Shoulder Injury Related to Vaccine Administration: Diagnosis and Management

Wood

Ilyas

2022

Journal of Hand Surgery Global Online

View full text Add to dashboard Cite

Purpose Shoulder injury related to vaccine administration (SIRVA) is a rare but potentially debilitating injury characterized by persistent shoulder pain, typically occurring within 48 hours of intramuscular deltoid vaccine administration. With over 150 million flu vaccines being administered in the United States each year, and the US Centers for Disease Control’s goal of immunizing greater than 70% of the population for the coronavirus disease 2019 virus, cases of SIRVA can be expected to rise. Methods A search of current literature was done to identify published material corresponding to incidence, diagnosis, and treatment of SIRVA. Results Most events have been associated with poor needle placement and/or a local reaction to the delivered serum during vaccine administration. Shoulder injury related to vaccine administration events can lead to persistent and possibly permanent injury. Clinical evaluation involves a thorough history, physical examination, and often diagnostic studies including radiographs, magnetic resonance imaging, and nerve studies. Treatment is individually directed and should initially consist of observation and local symptom management. Recalcitrant cases or infections may warrant surgical intervention. Published outcomes vary widely, and our understanding of SIRVA remains limited. Conclusions Large-scale studies are necessary to better understand the pathophysiology of SIRVA, its treatment, and its outcomes. Overall, the initial priority in managing SIRVA should be awareness and prevention.

show abstract

“…Whether or not the inflammatory response associated with vaccination turned a chronic, asymptomatic condition into an acute, symptomatic condition has yet to be evaluated, as well. Another interesting finding on MRI was solid-appearing heterogenous bodies within the subacromial space reported by Wong et al (15). Histologic review of these loose bodies revealed reactive changes and areas of tissue necrosis, findings not typical for synovial fluid (15).…”

Section: Imagingmentioning

confidence: 91%

Shoulder Injury Related to Vaccine Administration and a Growing Challenge: A Focused Review

Pettyjohn

Clugston

Zaremski

2022

Curr Sports Med Rep

View full text Add to dashboard Cite

Shoulder injury related to vaccine administration (SIRVA), an entity that causes acute shoulder pain and may limit range of motion (ROM) after vaccination, is a condition where a small but significant percentage of patients are experiencing in light of the current push for mass immunizations against SARS-CoV-2 worldwide. A search of literature related to SIRVA was performed across multiple electronic databases. Women, patients reporting vaccine injection location to be too high, and patients without prior history of shoulder pain were the most common historical factors in those experiencing SIRVA. Tenderness to palpation and limited shoulder ROM were the most associated physical examination findings. When using magnetic resonance imaging, tendinopathy, subacromial-subdeltoid bursitis, and rotator cuff tears (partial or complete) were the most common findings. Radiographic imaging rarely aided the diagnosis. SIRVA is an entity that health care providers should be aware of to improve the care of patients that may experience these symptoms after vaccine administration.

show abstract

Arthroscopic surgical management of shoulder secondary to shoulder injury related to vaccine administration (SIRVA): a case report

Cited by 9 publications

References 14 publications

Arthroscopic debridement for acute hemorrhagic subacromial bursitis following COVID-19 vaccine administration: A case report

Arthroscopic debridement for acute hemorrhagic subacromial bursitis following COVID-19 vaccine administration: A case report

Shoulder Injury Related to Vaccine Administration: Diagnosis and Management

Shoulder Injury Related to Vaccine Administration and a Growing Challenge: A Focused Review

Contact Info

Product

Resources

About